PreAxia’s quarterly net loss widened to $745,208 from $4,627 while Revenue stayed at $0. Investors also have cash and cash equivalents of $130,285 and a $0.02 basic and diluted loss per share to assess, alongside higher operating expenses and a larger weighted average share count.
Key Highlights
- Operating expenses increased to $576,134 from $4,627, with Research and Development accounting for $307,605.
- Cash and cash equivalents stood at $130,285, while Accounts Payable and accruals reached $47,163.
- Weighted average shares rose to 34,935,717 from 19,767,698 during the comparable periods.
PreAxia Health Care Payment Systems Inc. (OTC: PAXH) reported $0 in revenue and a net loss of $745,208 for the three months ended August 31, 2025. The comparable period recorded $0 in revenue and a net loss of $4,627.
Operating Costs Drive Loss
Operating expenses rose to $576,134 from $4,627. The company recorded consulting expense of $28,920, research and development expense of $307,605, management and labor expense of $192,360, professional fees of $31,809 and general and administrative expense of $15,440. Research and development spending was attributed to contractors and office costs allocated to developing new software. The company said its professional fees increased from $2,500 to $31,809, while general and administrative expense rose from $2,127 to $15,440. The operating loss was $576,134, compared with $4,627. Interest income was $82, interest expense was $13 and the loss on settlement was $169,143. Net loss before income taxes was $745,208, with income tax expense of $0. Net loss was $745,208. Other comprehensive income was $2,958, resulting in a net comprehensive loss of $742,250, compared with $4,627 in the comparable period.
Cash Position Totals $130,285
Cash and cash equivalents were $130,285 as of August 31, 2025. Total current Assets and total assets were also $130,285. Accounts payable and accruals were $47,163, compared with $43,683 at the earlier balance-sheet date.
Share Count Expands
Weighted average shares increased to 34,935,717 from 19,767,698. The company reported common stock with a $0.001 par value.
Disclosure Controls Rated Ineffective
Management concluded that disclosure controls and procedures were not effective as of August 31, 2025. The company reported that no changes during the quarter materially affected, or were reasonably likely to materially affect, internal control over financial reporting.



Please wait processing your request...